These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10693512)

  • 21. Practical nursing: intravenous infusion.
    Thomas S
    Nurs Mirror; 1979 Apr; 148(14):34-8. PubMed ID: 254222
    [No Abstract]   [Full Text] [Related]  

  • 22. [The conditions for decreasing the risk and increasing the efficacy of infusion therapy].
    Levité EM
    Feldsher Akush; 1992 Jan; 57(1):33-6. PubMed ID: 1397360
    [No Abstract]   [Full Text] [Related]  

  • 23. Straight to the veins: extending the role of the nurse in intravenous therapy.
    Marks M
    Nurs Mirror; 1979 Aug; 149(7):i-xi. PubMed ID: 112584
    [No Abstract]   [Full Text] [Related]  

  • 24. Three steps to effective wound care.
    Casey G
    Nurs Stand; 2000 Jun 21-27; 14(40):58, 61. PubMed ID: 11974183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraosseous infusion: a lifesaving technique.
    King ML; Moses EC
    Nursing; 1990 Jan; 20(1):32K, 32N-32P. PubMed ID: 2300286
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternatives to rehydration during hypodermoclysis.
    Woodall HE
    Am Fam Physician; 2002 Jul; 66(1):28; author reply 28, 30. PubMed ID: 12126032
    [No Abstract]   [Full Text] [Related]  

  • 27. Subcutaneous administration of immunoglobulin.
    Kirmse J
    J Infus Nurs; 2006; 29(3 Suppl):S15-20. PubMed ID: 16878851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypodermoclysis in the home and long-term care settings.
    Lybarger EH
    J Infus Nurs; 2009; 32(1):40-4. PubMed ID: 19142149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The benefits and drawbacks of syringe drivers in palliative care.
    Costello J; Nyatanga B; Mula C; Hull J
    Int J Palliat Nurs; 2008 Mar; 14(3):139-44. PubMed ID: 18414338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe hemorrhage from a hypodermoclysis site.
    O'Hanlon S; Sheahan P; McEneaney R
    Am J Hosp Palliat Care; 2009; 26(2):135-6. PubMed ID: 19136643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypodermoclysis, an undervalued rehydration method in geriatrics].
    Olde Rikkert MG; Bogaers MA; Bruijns E
    Tijdschr Gerontol Geriatr; 1994 Oct; 25(5):197-204. PubMed ID: 7974642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraosseous infusions.
    Tidwell B; Parks BR
    Pediatr Nurs; 1991; 17(1):56-7. PubMed ID: 2000242
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypodermoclysis therapy. In a chronic care hospital setting.
    Worobec G; Brown MK
    J Gerontol Nurs; 1997 Jun; 23(6):23-8. PubMed ID: 9197621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous fluid administration and the hydration of older people.
    Gabriel J
    Br J Nurs; 2014 Jul 24-Aug 13; 23(14):S10, S12-4. PubMed ID: 25158361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypodermoclysis (HDC) for symptom control vs. the Edmonton Injector (EI).
    Fainsinger RL; Bruera E
    J Palliat Care; 1991; 7(4):5-8. PubMed ID: 1783966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intravenous perfusion: placement and monitoring].
    Bregetzer J
    Rev Infirm; 1984 Jan; 34(1):37-46. PubMed ID: 6560736
    [No Abstract]   [Full Text] [Related]  

  • 37. Amnioinfusion. A review.
    Paszkowski T
    J Reprod Med; 1994 Aug; 39(8):588-94. PubMed ID: 7996522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performing I.V. procedures like an expert: 10 questions about I.V. therapy--and the revealing answers (continuing education credit).
    Millam DA
    Nurs Life; 1986; 6(1):33-40. PubMed ID: 3633055
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypodermoclysis: benefits and indications in geriatrics].
    Dardaine-Giraud V; Lamandé M; Constans T
    Rev Med Interne; 2005 Aug; 26(8):643-50. PubMed ID: 16023267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Subcutaneous drug administration. Indications for the use in terminal patients].
    Postigo Mota S; Llerena Ruiz A; Lavado García JM; Norberto Gamero MJ; Durán Gómez N
    Rev Enferm; 1999 Dec; 22(12):887-90. PubMed ID: 10797775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.